Researcher biography

Dr. Liviu-Gabriel Bodea currently holds an University of Queensland RSA2 Fellow position at the Queensland Brain Institute. He was the recipient of the Peter Hilton Early Career Fellowship at the Clem Jones Centre for Ageing Dementia Research (Brisbane, Australia), following the conferral of his Dr.rer.nat. (PhD) title from the University of Bonn (Germany).

Liviu is a brain cell biologist with a focus on the functional crosstalk between microglia, the resident immune cells of the brain parenchyma, and the surrounding cell types, both in health and disease. His research led to the identification of the microglial TYROBP adaptor protein as one of the top causal factors of late onset Alzheimer's disease (Cell 2013), and he provided evidence for the complement-induced neurodegeneration of dopaminergic neurons following immune stimulation (JNeurosci 2014). More recently, he coordinated studies that centred on the effect of tau on proteins synthesis (EMBO J 2019; ActaNeuropatholCommun 2021), the use of non-canonical amino acids for the investigation of memory (eLife 2020), and the role of neuronal PTEN enzyme in synaptic engulfment by microglia (ActaNeuropathol 2020).

Liviu has significant experience in generating and analysing both in vivo and in vitro models (from stable cell lines and primary cultures, to genetically modified mice) in combination with various biochemical and molecular techniques, ranging from high-end confocal imaging to functional pathway analysis and CRISPR gene editing.

In addition, Liviu has extensive experience in guiding both under- and post-graduate students into the wonders of scientific research :)